Literature DB >> 20014155

Integrating structural and epidemiological research to inform the classification of psychopathology.

Ayelet Meron Ruscio1.   

Abstract

Given the enormous influence of classification on the major clinical, research, and administrative activities of mental health professionals, understanding the true number and nature of disorders and the reasons for their comorbidity is an important public health priority. However, while studies of latent structure have yielded valuable information about disorder boundaries, their reliance on non-representative samples and failure to evaluate the practical implications of structural findings has limited their ability to effect nosological change. Conversely, community epidemiology studies, which inform classification by assessing the implications of diagnostic criteria in representative samples, have been limited by their focus on mental disorders as they are currently conceptualized by the field rather than on correlates and consequences of these disorders as they actually exist in nature. I consider the potential value of integrating systematically the methods of structural research with the methods of epidemiological research, exploring five ways in which these largely independent traditions may profitably be combined to inform the next classifications of mental disorders. By capitalizing on the complementary strengths of structural and epidemiological research, an integrated approach has significant potential to advance understanding of the nature of psychopathology and improve the validity and utility of its diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 20014155      PMCID: PMC3548397          DOI: 10.1002/mpr.295

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  42 in total

Review 1.  Adult psychopathology: issues and controversies.

Authors:  T A Widiger; L M Sankis
Journal:  Annu Rev Psychol       Date:  2000       Impact factor: 24.137

Review 2.  Toward DSM-V and the classification of psychopathology.

Authors:  T A Widiger; L A Clark
Journal:  Psychol Bull       Date:  2000-11       Impact factor: 17.737

3.  ONE CAUSE?MANY CAUSES?THE ARGUMENT FROM THE BIMODAL DISTRIBUTION.

Authors:  E A MURPHY
Journal:  J Chronic Dis       Date:  1964-04

4.  Clarifying boundary issues in psychopathology: the role of taxometrics in a comprehensive program of structural research.

Authors:  John Ruscio; Ayelet Meron Ruscio
Journal:  J Abnorm Psychol       Date:  2004-02

5.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

Authors:  T A Brown; B F Chorpita; D H Barlow
Journal:  J Abnorm Psychol       Date:  1998-05

6.  Can categorical and dimensional views of psychiatric illness be distinguished?

Authors:  D A Grayson
Journal:  Br J Psychiatry       Date:  1987-09       Impact factor: 9.319

7.  The structure of common mental disorders.

Authors:  R F Krueger
Journal:  Arch Gen Psychiatry       Date:  1999-10

Review 8.  Comorbidity (psycho) analysed.

Authors:  H M van Praag
Journal:  Br J Psychiatry Suppl       Date:  1996-06

9.  Using taxometric analysis to distinguish a small latent taxon from a latent dimension with positively skewed indicators: the case of involuntary defeat syndrome.

Authors:  John Ruscio; Ayelet Meron Ruscio; Terence M Keane
Journal:  J Abnorm Psychol       Date:  2004-02

10.  Important questions remain to be addressed before adopting a dimensional classification of mental disorders.

Authors:  Ayelet Meron Ruscio
Journal:  Am Psychol       Date:  2008-01
View more
  2 in total

1.  The latent structure of social anxiety disorder: consequences of shifting to a dimensional diagnosis.

Authors:  Ayelet Meron Ruscio
Journal:  J Abnorm Psychol       Date:  2010-11

2.  Taxometric analysis of DSM-IV and DSM-5 alcohol use disorders.

Authors:  Bradley T Kerridge; Tulshi D Saha; Gerhard Gmel; Jürgen Rehm
Journal:  Drug Alcohol Depend       Date:  2012-11-02       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.